MiMedx Group, Inc. Proceeds from (Repurchase of) Equity
MiMedx Group, Inc. (MDXG) reported Proceeds from (Repurchase of) Equity of -$7.57 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepurchaseOfEquity · last filed 2020-03-17
- MiMedx Group, Inc. proceeds from (repurchase of) equity for the quarter ending 2017-12-31 was -$24.23M.
- MiMedx Group, Inc. proceeds from (repurchase of) equity for the quarter ending 2017-09-30 was -$29.29M.
- MiMedx Group, Inc. proceeds from (repurchase of) equity for the quarter ending 2017-06-30 was -$2.08M.
- MiMedx Group, Inc. proceeds from (repurchase of) equity for the quarter ending 2017-03-31 was -$12.67M.
- MiMedx Group, Inc. proceeds from (repurchase of) equity for fiscal 2018 was -$7.57M.
- MiMedx Group, Inc. proceeds from (repurchase of) equity for fiscal 2017 was -$68.26M.
- MiMedx Group, Inc. proceeds from (repurchase of) equity for fiscal 2016 was -$10.38M.
- MiMedx Group, Inc. proceeds from (repurchase of) equity for fiscal 2015 was -$40.28M.
| Period end | Proceeds from (Repurchase of) Equity 3 month | Proceeds from (Repurchase of) Equity 6 month | Proceeds from (Repurchase of) Equity 6 month as first filed | Proceeds from (Repurchase of) Equity 9 month | Proceeds from (Repurchase of) Equity 9 month as first filed | Proceeds from (Repurchase of) Equity 12 month |
|---|---|---|---|---|---|---|
| 2018-12-31 | -$7.57M 10-K · filed 2020-03-17 | |||||
| 2017-12-31 | -$24.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | -$53.52M derived: sum of 2 quarters · filed 2020-03-17 | -$55.60M derived: sum of 3 quarters · filed 2020-03-17 | -$68.26M 10-K · filed 2020-03-17 | ||
| 2017-09-30 | -$29.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$31.37M derived: sum of 2 quarters · filed 2017-10-31 | -$44.03M 10-Q · filed 2017-10-31 | -$44.03M derived: sum of 4 quarters · filed 2020-03-17 | ||
| 2017-06-30 | -$2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | -$14.74M 10-Q · filed 2017-07-31 | -$14.74M derived: sum of 3 quarters · filed 2020-03-17 | -$21.59M derived: sum of 4 quarters · filed 2020-03-17 | ||
| 2017-03-31 | -$12.67M 10-Q · filed 2017-05-01 | -$12.67M derived: sum of 2 quarters · filed 2020-03-17 | -$19.51M derived: sum of 3 quarters · filed 2020-03-17 | -$19.51M derived: sum of 4 quarters · filed 2020-03-17 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | -$6.85M derived: sum of 2 quarters · filed 2020-03-17 | -$6.85M derived: sum of 3 quarters · filed 2020-03-17 | -$10.38M 10-K · filed 2020-03-17 | ||
| 2016-09-30 | -$6.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$6.85M derived: sum of 2 quarters · filed 2017-10-31 | -$10.38M 10-Q · filed 2017-10-31 | -$29.59M derived: sum of 4 quarters · filed 2017-10-31 | ||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | -$3.53M 10-Q · filed 2017-07-31 | -$22.74M derived: sum of 3 quarters · filed 2017-07-31 | -$27.17M derived: sum of 4 quarters · filed 2017-07-31 | ||
| 2016-03-31 | -$3.53M 10-Q · filed 2017-05-01 | -$22.74M derived: sum of 2 quarters · filed 2017-05-01 | -$27.17M derived: sum of 3 quarters · filed 2017-05-01 | -$31.51M derived: sum of 4 quarters · filed 2017-05-01 | ||
| 2015-12-31 | -$19.21M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$23.64M derived: sum of 2 quarters · filed 2017-03-01 | -$27.98M derived: sum of 3 quarters · filed 2017-03-01 | -$40.28M 10-K · filed 2017-03-01 | ||
| 2015-09-30 | -$4.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$8.77M derived: sum of 2 quarters · filed 2016-11-08 | -$21.07M 10-Q · filed 2016-11-08 | -$21.37M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-06-30 | -$4.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | -$16.64M 10-Q · filed 2016-08-02 | -$16.94M derived: sum of 3 quarters · filed 2017-03-01 | -$17.69M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-03-31 | -$12.29M 10-Q · filed 2015-05-01 | -$12.60M derived: sum of 2 quarters · filed 2017-03-01 | -$13.34M derived: sum of 3 quarters · filed 2017-03-01 | -$17.91M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2014-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$1.05M derived: sum of 2 quarters · filed 2017-03-01 | -$5.61M derived: sum of 3 quarters · filed 2017-03-01 | -$5.61M 10-K · filed 2017-03-01 | ||
| 2014-09-30 | -$749.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$5.31M derived: sum of 2 quarters · filed 2015-11-06 | -$5.31M 10-Q · filed 2015-11-06 | -$5.31M 10-Q · filed 2014-11-10 | -$5.31M derived: sum of 4 quarters · filed 2017-02-22 | |
| 2014-06-30 | -$4.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$4.56M 10-Q · filed 2015-08-07 | -$4.56M 10-Q · filed 2014-08-11 | -$4.56M derived: sum of 3 quarters · filed 2017-02-22 | -$4.56M derived: sum of 4 quarters · filed 2017-02-22 | |
| 2014-03-31 | $0.00 10-Q · filed 2015-05-01 | $0.00 derived: sum of 2 quarters · filed 2017-02-22 | $0.00 derived: sum of 3 quarters · filed 2017-02-22 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $0.00 derived: sum of 2 quarters · filed 2017-02-22 | $0.00 10-K · filed 2017-02-22 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | ||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-11 | |||||
| 2012-12-31 | $0.00 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |